Pharmacokinetics of 9-nitrocamptothecin after single oral administrations in rats

被引:0
|
作者
Zhang, Chun-Yan [1 ]
Yin, Qi [2 ]
Li, Yu-Zhen [1 ]
Li, Chang-Ling [3 ]
机构
[1] Department of Pharmacy, People's Hospital, Peking University, Beijing 100044, China
[2] Department of Pharmacy, Beijing Hospital, Beijing 100730, China
[3] Department of Pharmacology, School of Pharmacology, Peking University, Beijing 100083, China
关键词
D O I
暂无
中图分类号
学科分类号
摘要
5
引用
收藏
页码:852 / 854
相关论文
共 50 条
  • [1] Effect of injection routes on pharmacokinetics and lactone/carboxylate equilibrium of 9-Nitrocamptothecin in rats
    Chen, Jun
    Ping, Qineng
    Guo, Jianxin
    Liu, Minling
    Cai, Baochang
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 340 (1-2) : 29 - 33
  • [2] Pharmacokinetics of lactone, carboxylate and total 9-nitrocamptothecin with different doses and administration routes in rats
    Chen, J
    Ping, QN
    Guo, JX
    Chu, XZ
    Song, MM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2006, 27 (02) : 53 - 59
  • [3] 抗癌新药9-Nitrocamptothecin
    郑震寰
    郑珩
    药学进展, 2001, (05) : 310 - 311
  • [4] Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio
    Chen, Jun
    Hu, Rong-Rong
    Yang, Xi-Xiong
    Gu, Wei
    Tian, Rong
    Gong, Fang
    Luo, Lei
    Fang, Fang
    Chen, Zhi-Peng
    Cai, Bao-Chang
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (04) : 925 - 929
  • [5] Pharmacology study of multiple oral doses of 9-nitrocamptothecin (9NC)
    Verschraegen, CF
    Harris, N
    Steger, M
    Kavanagh, JJ
    Kudelka, AP
    Giovanella, B
    Gupta, E
    ANNALS OF ONCOLOGY, 1998, 9 : 70 - 70
  • [6] Antitumor efficacy, toxicity and pharmacokinetics of 9-nitrocamptothecin: role of lactone ratio
    Jun Chen
    Rong-Rong Hu
    Xi-Xiong Yang
    Wei Gu
    Rong Tian
    Fang Gong
    Lei Luo
    Fang Fang
    Zhi-Peng Chen
    Bao-Chang Cai
    Cancer Chemotherapy and Pharmacology, 2013, 72 : 925 - 929
  • [7] Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration
    Ru, Ge
    Han, Limei
    Qing, Jin
    Sheng, Jianyong
    Li, Ruixiang
    Qiu, Mingfeng
    Wang, Jianxin
    DRUG DELIVERY, 2016, 23 (09) : 3417 - 3423
  • [8] A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors
    Yan, Zhao
    Zhu, Zhongling
    Li, Kai
    Chen, Peng
    Wang, Liuchun
    Huang, Chun
    Xue, Jinhuai
    Liu, Meijun
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (04) : 955 - 961
  • [9] A phase I pharmacokinetics study of 9-nitrocamptothecin in patients with advanced solid tumors
    Zhao Yan
    Zhongling Zhu
    Kai Li
    Peng Chen
    Liuchun Wang
    Chun Huang
    Jinhuai Xue
    Meijun Liu
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 955 - 961
  • [10] Rubitecan -: 9-Nitrocamptothecin -: Camptogen® -: Oncolytic
    不详
    DRUGS OF THE FUTURE, 2001, 26 (12) : 1216 - 1217